Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kohjin Bio CoTSE:177A -0.47%19 Days Payable is 17.93 as of Mar. 2026, which is 8% below its 10-year median of 19.57. GuruFocus rates TSE:177A with a GF Score™ of 19/100. The stock has 4 warning signs investors should review. Among 702 Biotechnology companies, Kohjin Bio Co ranks worse than 90.31% on this metric.
The historical data trend for Kohjin Bio Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:177A vs VRTX, REGN, RVMD: Days Payable Comparison
For the Biotechnology subindustry, Kohjin Bio Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kohjin Bio Co Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kohjin Bio Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Kohjin Bio Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Kohjin Bio Co's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kohjin Bio Co (TSE:177A) has a Days Payable of 17.93 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Kohjin Bio Co and its competitors. This is near median its historical median of 19.57. Over the past decade, Kohjin Bio Co's Days Payable has ranged from 14.87 to 41.76. According to the industry distribution chart, Kohjin Bio Co ranks #634 out of 702 companies in the Biotechnology industry, placing it in the top 90.3%.
Is Kohjin Bio Co's Days Payable too high?
Kohjin Bio Co's current Days Payable of 17.93 is near median its 10-year median of 19.57. Over the past 10 years, this metric has ranged from a low of 14.87 to a high of 41.76. The Biotechnology industry median Days Payable is 110.69. Kohjin Bio Co's value of 17.93 is 83.8% below this industry median. Based on the distribution chart, Kohjin Bio Co ranks #634 out of 702 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Kohjin Bio Co has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Kohjin Bio Co's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kohjin Bio Co ranks #634 out of 702 companies for Days Payable. This places Kohjin Bio Co in the lower half of its industry. The industry median Days Payable is 110.69. Kohjin Bio Co's value of 17.93 is 83.8% below this benchmark. Historically, Kohjin Bio Co's own Days Payable has ranged from 14.87 to 41.76 over the past decade. While the company's 10-year median is 19.57 vs. the industry median of 110.69, Kohjin Bio Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 110.69, based on 702 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kohjin Bio Co's current Days Payable of 17.93 is 83.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Kohjin Bio Co and its competitors. For the Biotechnology industry, the median Days Payable is 110.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kohjin Bio Co's current Days Payable is 17.93, which is near median its own 10-year median of 19.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kohjin Bio Co stock overvalued right now?
Kohjin Bio Co (TSE:177A) has a current Days Payable of 17.93. The current Days Payable is 17.93, which is near median its 10-year median of 19.57 and 83.8% below the Biotechnology industry median of 110.69. Kohjin Bio Co's overall GF Score™ is 19/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Kohjin Bio Co (TSE:177A), the current Days Payable is 17.93 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kohjin Bio Co Ltd is engaged in development, manufacture and sale of culture media (growing environments used for culturing microorganisms and cells) and contract manufacturing of processed cell products. It has manufacturing and sales of animal blood, sera, tissue culture media, media for microbiology testing, in vitro diagnostic agents, and cosmetics.
19GF Score
Get the complete analysis for TSE:177A
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:177A has been successfully added to your 
